fC6MQX

Poster Presentations – Monday, October 20, 10:30 am - 4:00 pmP850. Predictors of Hospital Readmissions Among Hispanics WithHepatitis C Related CirrhosisPradeep Atla, MD, MPH, Firdose Gill, DO, Bakht Roshan, MD,Muhammad Sheikh, MD, FACG, Division of Gastroenterology andHepatology, UCSF Fresno, Fresno, CA, Communtiy Regional MedicalCenter, Fresno, CA, Saint Agnes Medical Center, Fresno, CAP851. Serum Vitamin B12 Level Could Be a Novel Diagnostic Marker toPredict Cirrhosis in Patients With Chronic Liver DiseaseFrank Czul, MD, Andres Yarur, MD, Kalyan Bhamidimarri, MD,University of Miami, Miami, FLP852. Rescuing Liver Transplant Recipients From Severe RecurrentHepatitis C With Interferon Free TherapySiddesh Besur, MD, Phillipe Zamor, MD, Paul Schmeltzer, MD, MarkRusso, MD, Carolinas Medical Center, Charlotte, NCP853. Extrapulmonary Tuberculosis in Liver Transplant Recipients: CaseSeriesSiddesh Besur, MD, Paul Schmeltzer, MD, Phillipe Zamor, MD, MarkRusso, MD, Carolinas Medical Center, Charlotte, NCP854. An Unusual Case of Elevated AFP in a Hep C Cirrhotic PatientZaid Alnoah, MD, Jennifer Luke, MD, Field Willingham, MD, MPH,Ryan Ford, MD, Gastroenterology, Emory, Atlanta, GAP855. An Unusual Case of Disseminated Adenovirus Presenting as FocalHepatic LesionsZilla Hussain, MD, Gastroenterology, Dartmouth Hitchcock MedicalCenter, Lebanon, NHP856. Effectiveness of Triple Therapy With Boceprevir, PegylatedInterferon, and Ribavirin in Veteran Patients With Chronic Hepatitis CVirus InfectionChristian Andrade, MD, Brijesh Patel, MD, Adnan Muhammad, MD,Gitanjali Vidyarthi, MD, James A. Haley Veterans Affairs, Tampa, FL,Gastroenterology, University of South Florida, Tampa, FLP857. Results of Interferon Free HCV Therapy in a Clinical PracticeSettingKenda Al-Assi, Farhan Arif, MD, Melissa Horton, BS, Deborah Baker,LVN, Cheryl Levine, PhD, Dana Al-Assi, Reem Ghalib, MD, TexasClinical Research Institute, Arlington, TX, Texas Digestive DiseaseConsultants, Arlington, TX, Texas Health Physician Group, Arlington, TXP858. Porto-Arterial Fistula Creation as a Complication of TIPSProcedure Causing Occult GI BleedingDaniel Benasher, MD, Derrick Cheung, MD, Kelly Teagle, DO,Nnaemeka Anyadike, MD, Kadirawel Iswara, MD, FACG, James Park,MD, FACG, Aaron Winnick, MD, Sergei Sobolevsky, MD, David Mobley,MD, Rabin Rahmani, MD, FACG, Ira Mayer, MD, FACG, MaimonidesMedical Center, Brooklyn, NYP859. A Rare Case of Hepatocellular Carcinoma With Self-Embolizationand Regression of TumorKireet Agrawal, MBBS, MD, Nameer Al Mardini, MD, Kamal Agrawal,MD, Swedish American Hospital, Rockford, IL, University of Illinois,Rockford, IL, University College of Medical Sciences, New Delhi, IndiaP860. Hepatitis C Associated Dermatomyositis and Lupus ComplicatingTreatmentImran Solaiman, MD, Kathryn White, DO, Jeff Hunt, DO, FACOI,University of Oklahoma Tulsa, Tulsa, OK, Oklahoma State University,Tulsa, OKP861. Results From the Phase 2 PEARL-I Study: Interferon-Free Regimensof ABT-450/r + ABT-267 With or Without Ribavirin in Patients With HCVGenotype 4 InfectionChristophe Hezode, MD, Patrick Marcellin, MD, PhD, Stanislas Pol,MD, Tarek Hassanein, MD, FACG, Katarzyna Fleischer-Stepniewska,MD, Tolga Baykal, MD, Tianli Wang, PhD, Sandra Lovell, PhD, TamiPilot-Matias, PhD, Regis Vilchez, MD, PhD, Assistance PubliqueHopitaux de Paris, Paris, France, Hopital Beaujon Inserm Crb3 - U773- Service Hepatologie, Clichy, France, Université Paris Descartes etHôpital, Paris, France, Southern California Liver Centers and SouthernCalifornia Research Center, Coronado, CA, EMC Instytut MedycznySpolka Akcyjna, Wroclaw, Poland, AbbVie, Inc., North Chicago, ILP862. Sustained Virologic Response 12 Weeks Post-Treatment With ABT-450/Ritonavir/Ombitasvir and Dasabuvir With Ribavirin (SAPPHIRE I andII) Is Independent of Patient SubgroupsMaurizia Rossana Brunetto, MD, Mihály Makara, MD, HolgerHinrichsen, MD, PhD, John Hanson, MD, Michael Bennett, MD, EricLawitz, MD, Junyuan Xiong, MS, Eoin Coakley, MD, Tolga Baykal,MD, Guy Neff, MD, Liver Unit, University Hospital of Pisa, Pisa, Italy,Saint Laszlo Hospital, Budapest, Hungary, Gastroenterologisch-Hepatologisches Zentrum Kiel, Kiel, Germany, CharlotteGastroenterology and Hepatology, PLLC, Charlotte, NC, MedicalAssociates Research Group, San Diego, CA, Texas Liver Institute,University of Texas Health Science Center, San Antonio, TX, AbbVie,Inc., North Chicago, ILP863. Low Incidence of Hyperbilirubinemia Events With ABT-450/R/Ombitasvir and Dasabuvir With or Without Ribavirin inHCV Genotype-1Infected PatientsDavid Bernstein, MD, FACG, Naoky Tsai, MD, Tarek Hassanein, MD,FACG, Federico Rodriguez-Perez, MD, Manuel Romero-Gomez, MD,Rui Marinho, MD, PhD, Ramon Planas Vila, MD, Massimo Colombo,MD, Sandra Lovell, PhD, Jeffrey Enejosa, MD, Yan Luo, MD, PhD,Daniel Cohen, MD, Marcos Pedrosa, MD, PhD, K. Rajender Reddy,MD, FACG, Hofstra North Shore-LIJ School of Medicine, Manhasset,NY, The Queen’s Medical Center - Liver Center, Honolulu, HI,Southern California Liver Centers and Southern California ResearchCenter, Coronado, CA, Gastroenterology and Hepatic WellnessCenter, Santurce, Hospital Universitario Nuestra Senora De Valme,Seville, Spain, Centro Hospitalar Lisboa Norte, Medical School of Lisbon,Lisboa, Portugal, Hospital Germans TríasiPujol, CIBERehd, Badalona,Spain, University of Milan, Milan, Italy, AbbVie Inc., North Chicago, IL,University of Pennsylvania, Philadelphia, PAP864. Nonselective β-Blockers May Negatively Impact Survival inPatients With Decompensated Cirrhosis2014 ACG Presidential Poster AwardBradley Confer, DO, Mohannad Dugum, MD, Thimmaiah Theethira,MD, Ibrahim Hanouneh, MD, Rocio Lopez, MS, Nizar Zein, MD,Cleveland Clinic, Cleveland, OHP865. Seroprevalence and Associated Factors of Hepatitis E VirusInfection in Pig Handlers of Lima, PeruMartin Tagle, MD, Patricia Guzman, MD, Alessandra Ciliotta, MD,Roxana Gallegos, MD, Eduar Bravo, MD, Leandro Huayanay, MD,Universidad Peruana Cayetano Heredia, Lima, PeruP866. Screening for Hepatocellular Carcinoma Associated With MeetingMilan Criteria at DiagnosisRichard Kalman, MD, David Nunes, MD, Gastroenterology, BostonMedical Center, Boston, MAP867. Autoimmune Hepatitis With Inflammatory Bowel Disease Is Distinctand May Be More Refractory to Traditional TreatmentJames Bailey, MD, Gouri Sreepati, MD, Joshua Love, BS, MonikaFischer, MD, Raj Vuppalanchi, MD, Marwan Ghabril, MD, SamerGawrieh, MD, Eric Orman, MD, Naga Chalasani, MD, FACG, CraigLammert, MD, Indiana University, Indianapolis, INP868. Impact of Donation After Cardiac Death (DCD) Allografts onIncidence and Severity of Recurrent Hepatitis C (HCV) and Graft SurvivalPost Liver Transplantation (LT) for HCVShiva Kumar, MD, FACG, Liver Transplant Program, Aurora St. Luke’sMedical Center, Milwaukee, WIPOSTERSMONDAY77For more information on ACG 2014 and to register, visit www.acgmeetings.gi.org.